anticholinesterase agents การใช้

• Patients with mild-to-moderate ocular myasthenia are usually treated initially with oral anticholinesterase agents, Mestinon ( pyridostigmine ) being the most commonly employed.
• Alpha adrenergic agonists are recommended in addition to intravenous fluids to combat hypotension; anticholinesterase agents " have been proposed as a treatment option but have not been tested adequately ".
• Neostigmine methylsulfate, an anticholinesterase agent, has been used to target ChAT . In particular, use of neostigmine methylsulfate has been shown to have positive effects against congenital myasthenic syndrome.